- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Strata Critical Medical, Inc.(SRTA)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for SRTA
11/13/2026: SRTA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Strata Critical Medical, Inc. is a specialized healthcare logistics and clinical services provider, having recently pivoted from its legacy passenger air mobility business. The company's primary strength lies in its integrated 'One Call' model, which streamlines complex transplant logistics and provides critical perfusion staffing to hospitals nationwide. Growth is driven by the scaling of its specialized clinical service lines and increasing reliance by healthcare systems on outsourced medical services. Key risks include operational execution in a time-sensitive environment and potential competitive pressures from larger hospital service providers. The stock is currently best suited for growth-oriented investors who monitor the adoption rate of the company's integrated medical solutions.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company is in an early-stage growth phase following its transformation into a specialized healthcare services provider. |
| Momentum investor | Mixed fit | Momentum fit is conditional on a sustained positive trend in adoption of its integrated transplant solutions. |
| Value investor | Weak fit | The company's current valuation and growth-oriented model may not align with traditional value metrics. |
| Dividend investor | Weak fit | The company does not currently pay dividends, focusing instead on scaling its operations. |
| Low-risk investor | Weak fit | The company's small-cap status and recent business model pivot involve volatility and operational risk. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | As a small-cap stock with a recent business model pivot, shares may experience significant price fluctuations. |
| Valuation risk | Medium | Valuation is sensitive to future growth projections in the transplant services sector. |
| Competition risk (healthcare services) | Medium / high | The company faces established competitors in medical transportation and clinical staffing. |
| Business quality | Medium | The long-term franchise quality is currently being established following the transition to the medical services sector. |
| Dividend income | Low / none | Investors should not expect dividend income at the current stage of the company's growth. |
| Execution risk | Medium / high | Successfully integrating and scaling clinical services across a national footprint is operationally demanding. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 492.15M USD | Price to earnings Ratio - | 1Y Target Price 9.62 |
Price to earnings Ratio - | 1Y Target Price 9.62 | ||
Volume (30-day avg) 1.1M shares | Beta 2.56 | 52 Weeks Range 3.95 - 6.50 | Updated Date 11/14/2026 |
52 Weeks Range 3.95 - 6.50 | Updated Date 11/14/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.24 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Care Facilities
- BUY participation
- 88.9%
- Active BUY / eligible
- 8 / 9
- 30-Day BUY Count Change
- +6
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Rolling Over
The price momentum is slowing down and beginning to turn downward.

Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -52.22% | Avg. Invested days 24 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Logistics | Organ transport, transplant team logistics, and organ placement services. | Revenue is earned by providing essential, time-sensitive transport services for the transplant industry. |
| Clinical | NRP, organ preservation, cardiac perfusion, and ECMO services. | Revenue is earned by placing highly specialized medical professionals and equipment in hospitals. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-03 | When Before Market | Estimate 0.01 | Actual -0.05 |
Profitability
Profit Margin -8.84% | Operating Margin (TTM) -4.67% |
Management Effectiveness
Return on Assets (TTM) -2.47% | Return on Equity (TTM) -7.55% |
Valuation
Trailing PE - | Forward PE 138.89 | Enterprise Value 454.13M | Price to Sales(TTM) 1.75 |
Enterprise Value 454.13M | Price to Sales(TTM) 1.75 | ||
Enterprise Value to Revenue 1.7 | Enterprise Value to EBITDA 145.26 | Shares Outstanding 89.32M | Shares Floating 58.75M |
Shares Outstanding 89.32M | Shares Floating 58.75M | ||
Percent Insiders 14.28 | Percent Institutions 74.86 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

